Dr. Reddy’s Laboratories is a Generics/Biosimilars Manufacturer company operating in the pharmaceutical industry.
We are a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines because we believe ‘Good Health Can’t Wait’. We offer a portfolio of products and services, including APIs, generics, branded generics, biosimilars and OTC. Our therapeutic focus areas are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our primary markets include – the US, India, Russia & CIS countries, China, Brazil, and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to invest in businesses of the future. As an early adopter of sustainability and ESG frameworks, we released our first Sustainability Report in 2004. Our current ESG goals aim to set the bar high for the environment but also to drive access to healthcare for more than 1.5 bn by 2030.
Company type
Generics/Biosimilars Manufacturer
Products and services
Custom Manufacturing, Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Dr. Reddy’s Laboratories on Facebook
Connect with Dr. Reddy’s Laboratories on LinkedIn
Address
Dr. Reddy’s Laboratories, Elisabethenanlage 11, Basel, Switzerland, 4051
